The Phase III Clinical Trial of immunizing agent Human Normal Immunoglobulin for Intravenous Administration IP/EP, 5% and 10% Solution has been approved by the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization (CDSCO).
Over 7.93 lakh pharma opioid tablets, capsules, and injections have been found by Punjab Police in the last week. 6.82 lakh intoxicating tablets, 17169 narcotic injectables, 85442 intoxicating capsules, and 8648 vials of intoxicating syrup were discovered.
US Food and Drug Administration has given Breckenridge Pharmaceutical, a Natco Pharma partner, approval for an abbreviated new drug application for the injectable powder form of capazitide, 60 mg/1.5 ml (40 mg/ml).
US FDA has given Lupin permission to market its 40 mg and 80 mg Azilsartan Medoxomil tablets under an Abbreviated New Drug Application (ANDA). The main purpose of the medication is to lower high blood pressure.
Subject Expert Committee, which advises the drug regulator on the approval of oncology and hematology drugs, has advised granting Novartis Healthcare’s ruxolitinib tablets permission for an additional indication in patients 12 years of age and older.
Small and medium pharma company representatives have recommended that the government use a “one molecule-one MRP” formula rather than trade margin rationalization (TMR) for non-scheduled medications to lower their costs.
The Indian Medical Associations have urged
the United Nations agency for global public
health to designate the virus as a sexually
transmitted infection (STI) because 100%
of cases are currently transmitted sexually.
If you don’t already have an account click the button below to create your account.Create New Account